DeepMind Discusses the Path to Bioresilience
bookofjoe · hn · 2026-07-19
The article outlines the perspective of Google DeepMind and Isomorphic Labs on "bioresilience": using AI to further understand biological systems, improve responses to biological threats and health risks, and integrate model capabilities, experimental validation, and biological domain knowledge.
The core message isn't about a single product launch, but rather an elaboration on their long-term view of AI's role in biosecurity, drug discovery, and biological system modeling, and why research, experimentation, and real-world constraints must be advanced within a unified framework.
More from Companies & People
- Investor argues Palantir-Nvidia partnership should slash Anthropic's IPO valuation — pdamodaran · 2026-09-11
- PyTorch Day Korea 2026 launches first offline conf, CFP closes Sept 13 — PyTorch · 2026-09-11
- Class action accuses Anthropic of overselling Claude subscriptions with deceptive usage multipliers — The Decoder · 2026-09-11
- AI post-training and evals jobs pay up to $850K, with median offers at $210K–$325K — FinanceYF5 · 2026-09-11
- Only a 4-day window: timeline casts doubt on OpenAI's independent math result claim — gleech · 2026-09-11
- 89% of firms use AI, only 6% see significant ROI — the busywork illusion — mikeflache · 2026-09-11